AGP Executive Report
Last update: 3 hours agoRare-Disease Access: The maker of a muscular-dystrophy drug says it will stop supplying Canada, as a B.C. family calls for a national rare-disease strategy. Assistive Technology: A Montreal woman with ALS is using an AI tool that recreates her voice, helping her reconnect with family conversations. Vaccines: Health Canada has approved Moderna’s mRNA flu vaccine and combined flu-COVID shot; a federal advisory committee also recommends hepatitis B vaccination for all infants. Mental Health Care: Ottawa’s $29-billion homelessness plan puts treatment in focus, with a mental-health and addictions centre promised for Winnipeg. Consumer Safety: Health Canada recalled several Molson Coors beer products across Canada over possible metal fragments; the company says no injuries have been reported.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.